Chemoinformaics analysis of METHYL 2,4-DI-O-METHYL-ALPHA-D-GLUCOPYRANOSIDE
| Molecular Weight | 222.237 | nRot | 4 |
| Heavy Atom Molecular Weight | 204.093 | nRig | 6 |
| Exact Molecular Weight | 222.11 | nRing | 1 |
| Solubility: LogS | 0.475 | nHRing | 1 |
| Solubility: LogP | -1.148 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 31.8443 |
| nHD | 2 | BPOL | 25.0017 |
| QED | 0.618 |
| Synth | 3.754 |
| Natural Product Likeliness | 2.217 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.157 |
| HIA | 0.728 |
| CACO-2 | -5.16 |
| MDCK | 0.000181833 |
| BBB | 0.344 |
| PPB | 0.110871 |
| VDSS | 0.672 |
| FU | 0.821317 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.543 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.603 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.023 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.158 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.146 |
| CL | 2.175 |
| T12 | 0.334 |
| hERG | 0.036 |
| Ames | 0.368 |
| ROA | 0.106 |
| SkinSen | 0.094 |
| Carcinogencity | 0.046 |
| EI | 0.024 |
| Respiratory | 0.017 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.838338 |